Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

Authors

Varduhi Petrosyan, Baylor College of Medicine
Shunqiang Li, Washington University School of Medicine in St. Louis
et al.

Journal

iScience

Publication Date

1-20-2023

Volume

26

Issue

1

First Page

105799

Document Type

Open Access Publication

DOI

10.1016/j.isci.2022.105799

Rights and Permissions

Petrosyan V, Dobrolecki LE, Thistlethwaite L, Lewis AN, Sallas C, Srinivasan RR, Lei JT, Kovacevic V, Obradovic P, Ellis MJ, Osborne CK, Rimawi MF, Pavlick A, Shafaee MN, Dowst H, Jain A, Saltzman AB, Malovannaya A, Marangoni E, Welm AL, Welm BE, Li S, Wulf GM, Sonzogni O, Huang C, Vasaikar S, Hilsenbeck SG, Zhang B, Milosavljevic A, Lewis MT. Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach. iScience. 2022 Dec 12;26(1):105799. doi: 10.1016/j.isci.2022.105799. Copyright 2022 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Petrosyan, Varduhi; Li, Shunqiang; and et al., "Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach." iScience. 26, 1. 105799 (2023).
https://digitalcommons.wustl.edu/oa_4/2421

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.